Abeona Therapeutics, Inc. (ABEO)
6.075
-0.02
(-0.25%)
USD |
NASDAQ |
Aug 24, 16:00
6.075
0.00 (0.00%)
After-Hours: 20:00
Abeona Therapeutics Gross Profit Margin (Quarterly) : 57.45% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 57.45% |
| March 31, 2026 | 59.12% |
| December 31, 2025 | 31.73% |
| September 30, 2025 | |
| June 30, 2025 | -117.0% |
| March 31, 2025 | |
| December 31, 2024 | |
| September 30, 2024 | |
| June 30, 2024 | |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | 76.06% |
| March 31, 2023 | |
| December 31, 2022 | -1.38K% |
| September 30, 2022 | |
| June 30, 2022 | -37.00% |
| March 31, 2022 | -221.7% |
| December 31, 2021 | 60.13% |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 72.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 |
| Date | Value |
|---|---|
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | 96.15% |
| September 30, 2014 | 99.58% |
| June 30, 2014 | 99.60% |
| March 31, 2014 | 0.00% |
| December 31, 2013 | 99.38% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 98.41% |
| Forum Markets, Inc. | -39.41% |
| ACADIA Pharmaceuticals, Inc. | 90.81% |
| Alnylam Pharmaceuticals, Inc. | 76.88% |
| Anika Therapeutics, Inc. | 65.15% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -40.99% |
| Return on Assets | -29.21% |
| Return on Invested Capital | -35.60% |
| Profit Margin (Quarterly) | -177.4% |
| Operating Margin (Quarterly) | -120.0% |
| Return on Net Operating Assets | -267.7% |